• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫功能低下患者腺病毒感染的诊断与治疗。

Diagnosis and treatment of adenovirus infection in immunocompromised patients.

机构信息

St Anna Children's Hospital, Stem cell transplantation, Medical University of Vienna, Vienna, Austria.

出版信息

Expert Rev Anti Infect Ther. 2013 Oct;11(10):1017-28. doi: 10.1586/14787210.2013.836964. Epub 2013 Sep 27.

DOI:10.1586/14787210.2013.836964
PMID:24073835
Abstract

In immunocompromised patients, human adenovirus (HAdV) infections can cause life-threatening multiorgan disease. This review summarizes the incidence and risk factors of invasive human adenovirus infections in immunocompromised patients as well as the recently developed standards for diagnostic methods and strategies according to the predominant risk factors in adults and children. Recommendations for preemptive and therapeutic treatment strategies and the outcome in different risk groups are presented. Novel therapeutic approaches including CMX001, a new orally bioavailable lipid conjugate of cidofovir and the transfer of adenovirus-specific donor T cells in the context of allogeneic stem cell transplantation are discussed.

摘要

在免疫功能低下的患者中,人类腺病毒(HAdV)感染可导致危及生命的多器官疾病。本综述总结了免疫功能低下患者侵袭性人类腺病毒感染的发生率和危险因素,以及根据成人和儿童的主要危险因素制定的最新诊断方法和策略标准。本文还介绍了针对不同风险群体的预防性和治疗性治疗策略及结果。本文还讨论了包括 CMX001 在内的新型治疗方法,CMX001 是一种新的口服生物可利用的西多福韦脂质缀合物,以及同种异体干细胞移植背景下腺病毒特异性供体 T 细胞的转移。

相似文献

1
Diagnosis and treatment of adenovirus infection in immunocompromised patients.免疫功能低下患者腺病毒感染的诊断与治疗。
Expert Rev Anti Infect Ther. 2013 Oct;11(10):1017-28. doi: 10.1586/14787210.2013.836964. Epub 2013 Sep 27.
2
The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution.西多福韦对未进行T细胞重建的干细胞移植受者腺病毒血浆DNA水平的影响。
Biol Blood Marrow Transplant. 2015 Feb;21(2):293-9. doi: 10.1016/j.bbmt.2014.10.012. Epub 2014 Oct 16.
3
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients.CMX001 作为免疫功能低下患者严重腺病毒感染的挽救疗法的安全性和疗效。
Biol Blood Marrow Transplant. 2012 May;18(5):731-8. doi: 10.1016/j.bbmt.2011.09.007. Epub 2011 Sep 29.
4
Immune reconstitution and cidofovir administration rescue human adenovirus hepatitis after allogeneic hematopoietic cell transplantation.免疫重建和更昔洛韦治疗挽救异基因造血细胞移植后人类腺病毒肝炎。
Transpl Immunol. 2024 Oct;86:102093. doi: 10.1016/j.trim.2024.102093. Epub 2024 Jul 19.
5
Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001.新型抗病毒药物 CMX001 清除小儿造血干细胞移植受者播散性腺病毒感染
J Clin Virol. 2011 Feb;50(2):167-70. doi: 10.1016/j.jcv.2010.10.016. Epub 2010 Nov 19.
6
Adenovirus infection after allogeneic stem cell transplantation.异基因造血干细胞移植后的腺病毒感染
Leuk Lymphoma. 2007 Feb;48(2):244-55. doi: 10.1080/10428190600881157.
7
Antiviral therapy for adenovirus infections.腺病毒感染的抗病毒治疗。
Antiviral Res. 2006 Sep;71(2-3):172-80. doi: 10.1016/j.antiviral.2006.04.007. Epub 2006 May 2.
8
New drug on the horizon for treating adenovirus.治疗腺病毒的新药即将问世。
Expert Opin Pharmacother. 2015;16(14):2095-9. doi: 10.1517/14656566.2015.1083975. Epub 2015 Sep 2.
9
Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant.布林西多福韦作为挽救疗法用于控制造血干细胞移植儿科受者的腺病毒血症
J Pediatr Hematol Oncol. 2019 Oct;41(7):e467-e472. doi: 10.1097/MPH.0000000000001480.
10
Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植患者腺病毒感染的治疗
Clin Infect Dis. 2001 May 1;32(9):1290-7. doi: 10.1086/319984. Epub 2001 Apr 10.

引用本文的文献

1
Treating Adenovirus Infection in Transplant Populations: Therapeutic Options Beyond Cidofovir?治疗移植人群中的腺病毒感染:除西多福韦之外的治疗选择?
Viruses. 2025 Apr 23;17(5):599. doi: 10.3390/v17050599.
2
Identification and characterization of a novel human adenovirus type HAdV-D116.新型人类腺病毒HAdV-D116的鉴定与特性分析
Front Microbiol. 2025 May 7;16:1566316. doi: 10.3389/fmicb.2025.1566316. eCollection 2025.
3
Virus-Specific T-Cell Therapy for Viral Infections of the Central Nervous System: A Review.病毒特异性 T 细胞疗法治疗中枢神经系统病毒感染:综述。
Viruses. 2023 Jul 6;15(7):1510. doi: 10.3390/v15071510.
4
How I prevent viral reactivation in high-risk patients.我是如何预防高危患者病毒再激活的。
Blood. 2023 Apr 27;141(17):2062-2074. doi: 10.1182/blood.2021014676.
5
Adenoviral Infections in Neonates: A Case-Based Literature Review.新生儿腺病毒感染:基于病例的文献综述
Cureus. 2022 Sep 12;14(9):e29082. doi: 10.7759/cureus.29082. eCollection 2022 Sep.
6
Human Mastadenovirus Infections in Children: A Review of the Current Status in the Arab World in the Middle East and North Africa.儿童人乳腺病毒感染:中东和北非阿拉伯世界现状综述
Children (Basel). 2022 Sep 6;9(9):1356. doi: 10.3390/children9091356.
7
Adenovirus Infection in Pediatric Hematopoietic Cell Transplantation: A Challenge Still Open for Survival.儿童造血细胞移植中的腺病毒感染:生存方面仍面临的挑战
J Clin Med. 2022 Aug 18;11(16):4827. doi: 10.3390/jcm11164827.
8
Validation of a Classification Model Using Complete Blood Count to Predict Severe Human Adenovirus Lower Respiratory Tract Infections in Pediatric Cases.使用全血细胞计数预测小儿严重人腺病毒下呼吸道感染的分类模型验证
Front Pediatr. 2022 May 27;10:896606. doi: 10.3389/fped.2022.896606. eCollection 2022.
9
Adenovirus entry: Stability, uncoating, and nuclear import.腺病毒进入:稳定性、脱壳和核输入。
Mol Microbiol. 2022 Oct;118(4):309-320. doi: 10.1111/mmi.14909. Epub 2022 Apr 26.
10
Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and Cytopathology.组织病原体与癌症:组织病理学和细胞病理学中常见表现的综述
Pathogens. 2021 Oct 30;10(11):1410. doi: 10.3390/pathogens10111410.